You are here: HomeSolutionsIndustriesConsumer Health
print my pages

Country Report

Consumer Health in Sweden

Jun 2012

Price: US$2,400

About this Report

EXECUTIVE SUMMARY

Continuing value growth for consumer health

Consumer health in Sweden had positive value growth in 2011, representing a continuation of the annual growth trend in the review period. Swedish consumer health was unaffected by the poor economic performances in other countries. Nevertheless, there was increased price competition in 2011 due to the growth of private label.

Consumer health awareness is a key theme

A key underlying theme dominating sales was the increased health consciousness of consumers. Swedish consumers are becoming more interested in their health and well-being, a trend reflected in the value growth of consumer health. This is especially apparent in value growth of weight management, sports nutrition and vitamins and dietary supplements. Players are therefore positioning their products to address this trend more effectively. This is being achieved through greater product availability and distribution combined with increased product segmentation to address specific niche demands.

Multinationals lead sales

Multinationals are the leading players in Swedish consumer health. This is particularly evident in OTC sales where international brand names such as Panodil lead in their respective categories. Domestic players enjoy stronger value shares and positions in weight management, sports nutrition and vitamin and dietary supplements. For example, the new company Midsona Sverige AB, formed following the merger of Friggs AB and MaxMedica AB in 2011, is the leading player in vitamins and dietary supplements.

Chemists/pharmacies is leading distribution channel

The chemists/pharmacies channel led consumer health in 2011 and throughout the review period. However, the de-regulation of OTC medicine sales in 2009 led to a clear shift in channel sales to the benefit of grocery retailers, other non-grocery retailers and internet retailing. Changes in the distribution of consumer health products also had implications for their pricing, with price promotions and price discounting more evident in 2011, increasing the value growth of consumer health.

Growth expected over the forecast period

The value of consumer health is expected to increase in the forecast period. However, it will be slower than in the review period. 2011 saw a significant increase in the availability and visibility of private label. Both price promotion activities and private label are expected to become more dominant characteristics of Swedish consumer health in the forecast period. This will have a negative impact on value growth rates in the forecast period which will result in slower forecast period growth compared to review period growth.


Samples (FAQs about samples):

doc_pdf.png Sample Consumer Health Market Research Report

doc_excel_table.png Sample Consumer Health Data

Delivery: Files are delivered directly into your account within a few minutes of purchase.

Overview

Discover the latest market trends and uncover sources of future market growth for the Consumer Health industry in Sweden with research from Euromonitor's team of in-country analysts.

Find hidden opportunities in the most current research data available, understand competitive threats with our detailed market analysis, and plan your corporate strategy with our expert qualitative analysis and growth projections.

If you're in the Consumer Health industry in Sweden, our research will save you time and money while empowering you to make informed, profitable decisions.

When you purchase this report, you also get the data and the content from these category reports in Sweden for free:

The Consumer Health in Sweden market research report includes:

  • Analysis of key supply-side and demand trends
  • Detailed segmentation of international and local products
  • Historic volumes and values, company and brand market shares
  • Five year forecasts of market trends and market growth  
  • Robust and transparent market research methodology, conducted in-country

Our market research reports answer questions such as:

  • What is the market size of Consumer Health in Sweden?
  • What are the major brands in Sweden?
  • What are the main trends in OTC Healthcare?

Why buy this report?

  • Gain competitive intelligence about market leaders
  • Track key industry trends, opportunities and threats
  • Inform your marketing, brand, strategy and market development, sales and supply functions

This industry report originates from Passport, our Consumer Health market research database.

Table of Contents

Table of Contents

Consumer Health in Sweden - Industry Overview

EXECUTIVE SUMMARY

Continuing value growth for consumer health

Consumer health awareness is a key theme

Multinationals lead sales

Chemists/pharmacies is leading distribution channel

Growth expected over the forecast period

KEY TRENDS AND DEVELOPMENTS

The economy – cause for optimism?

The impact of the ageing population

Obesity and its impact on consumer health

Self medication a key driving trend

The changing retailing landscape

MARKET INDICATORS

  • Table 1 Consumer Expenditure on Health Goods and Medical Services 2006-2011
  • Table 2 Life Expectancy at Birth 2006-2011

MARKET DATA

  • Table 3 Sales of Consumer Health by Category: Value 2006-2011
  • Table 4 Sales of Consumer Health by Category: % Value Growth 2006-2011
  • Table 5 Consumer Health Company Shares 2007-2011
  • Table 6 Consumer Health Brand Shares 2008-2011
  • Table 7 Penetration of Private Label by Category 2006-2011
  • Table 8 Sales of Consumer Health by Distribution Format: % Analysis 2006-2011
  • Table 9 Sales of Consumer Health by Category and Distribution Format: % Analysis 2011
  • Table 10 Forecast Sales of Consumer Health by Category: Value 2011-2016
  • Table 11 Forecast Sales of Consumer Health by Category: % Value Growth 2011-2016

APPENDIX

OTC Registration and Classification

Advertising

Standardised Packaging Requirements

Vitamins and Dietary Supplements Registration and Classification

Advertising

Self-medication/self-care and preventative medicine

Switches

  • Summary 1 OTC - Switches 2009-2011

DEFINITIONS

SOURCES

  • Summary 2 Research Sources

Consumer Health in Sweden - Company Profiles

Abigo Medical AB in Consumer Health (Sweden)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

  • Summary 5 Abigo Medical AB: Competitive Position 2011

Dalblads Nutrition AB in Consumer Health (Sweden)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

  • Summary 8 Dalblads Nutrition AB: Production Sites 2011

COMPETITIVE POSITIONING

  • Summary 9 Dalblads Nutrition AB: Competitive Position 2011

Green Medicine AB in Consumer Health (Sweden)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

  • Summary 12 Green Medicine AB: Competitive Position 2011

Meda AB in Consumer Health (Sweden)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

  • Summary 15 Meda AB: Competitive Position 2011

Midsona Sverige AB in Consumer Health (Sweden)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

  • Summary 17 Midsona Sverige AB: Production Sites 2011

COMPETITIVE POSITIONING

  • Summary 18 Midsona Sverige AB: Competitive Position 2011

Adult Mouth Care in Sweden - Category Analysis

HEADLINES

TRENDS

  • As with the rest of other OTC medicine, the growth of adult mouth care was strongly influenced by the growing self-medication trend. Consumers were more confident in their abilities to self-diagnose and self-medicate minor aliments and illness.

SWITCHES

COMPETITIVE LANDSCAPE

  • Ipex Medical AB leads sales with a 2011 value share of 31%. Ipex Medical is the national brand owner of the popular Dentan, Dentan Mint and Hexident brands. Dentan Mint is the leading brand in value terms with a share of 20% in 2011. Dentan Mint outperformed the unflavoured Dentan brand in the latter years of the review period indicating Swedish consumer preference for flavoured OTC mouthwash products. This suggests consumers perceive or prefer OTC mouthwash products to have a dual functionality, such as mouth care and mouth freshness.

PROSPECTS

  • The growing self-medication trend will remain the key driver of sales in the forecast period. Consistent with review period observations, consumers were more confident in their abilities to self-diagnose and medicate minor aliments. Combined with the de-regulation of pharmacy retailers and subsequent greater availability and distribution of adult mouth care products, the self medication trend will remain key to drive value growth beyond 2011 levels.

CATEGORY DATA

  • Table 12 Sales of Adult Mouth Care: Value 2006-2011
  • Table 13 Sales of Adult Mouth Care: % Value Growth 2006-2011
  • Table 14 Adult Mouth Care Company Shares by Value 2007-2011
  • Table 15 Adult Mouth Care Brand Shares by Value 2008-2011
  • Table 16 Forecast Sales of Adult Mouth Care: Value 2011-2016
  • Table 17 Forecast Sales of Adult Mouth Care: % Value Growth 2011-2016

Analgesics in Sweden - Category Analysis

HEADLINES

TRENDS

  • The self medication trend, consistent with development throughout Swedish consumer health, was a key trend that shaped analgesics sales in Sweden in 2011. Swedish consumers were more likely to self-medicate, thus benefiting sales of analgesics.

SWITCHES

COMPETITIVE LANDSCAPE

  • GlaxoSmithKline Sweden AB leads sales with value share of 36% in 2011. The company is the NBO of a number of important brands including Alvedon, Panodil and Reliv.

PROSPECTS

  • Pain deriving from the ageing process will boost future sales. In addition, liberalisation of consumer health and the self-medication trend will continue to have positive impacts on growth rates throughout the forecast period.

CATEGORY DATA

  • Table 18 Sales of Analgesics by Category: Value 2006-2011
  • Table 19 Sales of Analgesics by Category: % Value Growth 2006-2011
  • Table 20 Topical Analgesics/Anaesthetic by Format: % Value Breakdown 2006-2011
  • Table 21 Analgesics Company Shares by Value 2007-2011
  • Table 22 Analgesics Brand Shares by Value 2008-2011
  • Table 23 Forecast Sales of Analgesics by Category: Value 2011-2016
  • Table 24 Forecast Sales of Analgesics by Category: % Value Growth 2011-2016

Calming and Sleeping in Sweden - Category Analysis

HEADLINES

TRENDS

  • Calming and sleeping products distribution increased to include grocery retailers, other non-grocery retailers and non-store retailing channels. This helped calming and sleeping products to reach and appeal to new consumer segments, which in turn helped to drive value growth.

SWITCHES

COMPETITIVE LANDSCAPE

  • Cederroth AB is the market leader with value share of 41% in 2011. The company is the NBO of the leading Valerina brand. Unlike the majority of other calming and sleeping products, Valerina enjoys mass market distribution as it is stocked in grocery retailers, pharmacies and other healthcare specialist retailers. The wide and varied distribution network supports Valerina’s leading position and consequently Cederroth’s leading position.

PROSPECTS

  • Increased hectic lifestyles and a continuation of the self-medication trend mean good prospects for calming and sleeping during the forecast period in Sweden. Consumer confidence in their ability to self-diagnose and self-medicate minor aliments will remain an important driver of sales.

CATEGORY DATA

  • Table 25 Sales of Calming and Sleeping: Value 2006-2011
  • Table 26 Sales of Calming and Sleeping: % Value Growth 2006-2011
  • Table 27 Calming and Sleeping Company Shares by Value 2007-2011
  • Table 28 Calming and Sleeping Brand Shares by Value 2008-2011
  • Table 29 Forecast Sales of Calming and Sleeping: Value 2011-2016
  • Table 30 Forecast Sales of Calming and Sleeping: % Value Growth 2011-2016

Cough, Cold and Allergy (Hay Fever) Remedies in Sweden - Category Analysis

HEADLINES

TRENDS

  • The de-regulation of pharmacy retailing in 2009 continued to positively impact value growth of cough, cold and allergy (hay fever) remedies in 2011. De-regulation led to an increase in product availability and distribution as grocery retailers were permitted to sell certain cough, cold and allergy (hay fever) remedies previously restricted to chemists/pharmacies.

SWITCHES

COMPETITIVE LANDSCAPE

  • Procter & Gamble Sweden AB has leading value share of 17% in 2011. The company is the leader in medicated confectionery. The company’s leading brand, Vicks, benefits from a wide distribution network in Sweden.

PROSPECTS

  • Price competition represents a threat to forecast period growth due to the expected greater availability of private label. Retailer activities are expected to include increased discounting and price promotion activities during the forecast period which will also affect pricing. 2011 already witnessed chemists/pharmacies chains offering products on price promotion, a trend that will gather momentum in the forecast period given the increasingly crowded nature of chemists/pharmacies retailing in Sweden.

CATEGORY DATA

  • Table 31 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2006-2011
  • Table 32 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2006-2011
  • Table 33 Sales of Decongestants by Category: Value 2006-2011
  • Table 34 Sales of Decongestants by Category: % Value Growth 2006-2011
  • Table 35 Sales of Paediatric Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2008-2011
  • Table 36 Sales of Paediatric Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2008-2011
  • Table 37 Cough, Cold and Allergy (Hay Fever) Remedies Company Shares by Value 2007-2011
  • Table 38 Cough, Cold and Allergy (Hay Fever) Remedies Brand Shares by Value 2008-2011
  • Table 39 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2011-2016
  • Table 40 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2011-2016

Digestive Remedies in Sweden - Category Analysis

HEADLINES

TRENDS

  • The continued ageing of the Swedish population provided increasing demand for digestive remedies in Sweden. Ageing can lead to difficulties in digesting food. Acidity, heartburn and constipation continued to offer good opportunities for growth of digestive remedies in Sweden. According to research by Novartis, 36% of the Swedish population suffered from indigestion complaints in a given six month period. This statistic reveals the strong demand and growth potential for Swedish digestive remedies.

SWITCHES

COMPETITIVE LANDSCAPE

  • McNeil Sweden AB leads sales with a value share of 16% in 2011. McNeil Sweden is the NBO of several popular and leading digestive remedies brands in Sweden, including diarrhoeal remedy Imodium, H2 blocker Pepcid Duo and laxative Microlax.

PROSPECTS

  • The continuing ageing of the Swedish population combined with greater consumer confidence in their ability to self diagnose and medicate minor aliments will be key drivers of value growth for digestive remedies in Sweden over the forecast period.

CATEGORY DATA

  • Table 41 Sales of Digestive Remedies by Category: Value 2006-2011
  • Table 42 Sales of Digestive Remedies by Category: % Value Growth 2006-2011
  • Table 43 Digestive Remedies Company Shares by Value 2007-2011
  • Table 44 Digestive Remedies Brand Shares by Value 2008-2011
  • Table 45 Forecast Sales of Digestive Remedies by Category: Value 2011-2016
  • Table 46 Forecast Sales of Digestive Remedies by Category: % Value Growth 2011-2016

Ear Care in Sweden - Category Analysis

HEADLINES

TRENDS

  • The trend of self-medication was a key driver of value growth in 2011. Problems with ear wax are regarded as suitable for self-medication, and there are few who visit a doctor for this problem. For minor illnesses, self-medication was also encouraged by the health authorities in order to limit the pressure and cost to the overall health care system.

SWITCHES

COMPETITIVE LANDSCAPE

  • Orion Pharma AB leads sales with a value share of 62% in 2011. The company was the clear market leader of ear care throughout the review period. The company is the NBO of the Revaxör brand. Revaxör is the most widely distributed ear care brand. The low value of ear care in Sweden and traditional low levels of competition support Revaxör’s leading position.

PROSPECTS

  • Ear wax and ear care-related problems are particularly common with elderly consumers. The continued ageing of the Swedish population and continued trend towards self-medication offer growth opportunities for ear care.

CATEGORY DATA

  • Table 47 Sales of Ear Care: Value 2006-2011
  • Table 48 Sales of Ear Care: % Value Growth 2006-2011
  • Table 49 Ear Care Company Shares by Value 2007-2011
  • Table 50 Ear Care Brand Shares by Value 2008-2011
  • Table 51 Forecast Sales of Ear Care: Value 2011-2016
  • Table 52 Forecast Sales of Ear Care: % Value Growth 2011-2016

Emergency Contraception in Sweden - Category Analysis

HEADLINES

TRENDS

  • The market entry of parallel importers increased price competition in Swedish emergency contraception in 2011. Increased price competition contributed to a slowdown in value growth.

COMPETITIVE LANDSCAPE

  • Nycomed AB leads with a value share of 73% in 2011. The company is the NBO of the leading emergency contraception brand NorLevo. NorLevo was the first emergency contraception brand available in Sweden and therefore gained from first-mover advantage. Through first-mover advantage, the company built up a distribution network to support its position in 2011.

PROSPECTS

  • Increased price competition will continue to be a key trend shaping value growth in the forecast period.

CATEGORY DATA

  • Table 53 Sales of Emergency Contraception: Value 2006-2011
  • Table 54 Sales of Emergency Contraception: % Value Growth 2006-2011
  • Table 55 Emergency Contraception Company Shares by Value 2007-2011
  • Table 56 Emergency Contraception Brand Shares by Value 2008-2011
  • Table 57 Forecast Sales of Emergency Contraception: Value 2011-2016
  • Table 58 Forecast Sales of Emergency Contraception: % Value Growth 2011-2016

Eye Care in Sweden - Category Analysis

HEADLINES

TRENDS

  • The continued ageing of the population is a key underlying trend driving the value growth of eye care sales in Sweden. Minor aliments, such as dry eye, were representative of conditions linked to increasing age.

SWITCHES

COMPETITIVE LANDSCAPE

  • Novartis Sverige AB leads with a value share of 28% in 2011. The company’s strong market share is due to its Viscotears brand which leads standard eye care. Viscotears is a long-established brand name in eye care. Consumer brand recognition and loyalty to the brand helps to support and retain its leading position.

PROSPECTS

  • The growing self-medication trend, increased product distribution and the continuing ageing of the Swedish population will remain key factors in shaping forecast period value growth.

CATEGORY DATA

  • Table 59 Sales of Eye Care by Category: Value 2006-2011
  • Table 60 Sales of Eye Care by Category: % Value Growth 2006-2011
  • Table 61 Standard Eye Care by Format: % Value Breakdown 2007-2011
  • Table 62 Standard Eye Care by Positioning: % Value Breakdown 2007-2011
  • Table 63 Eye Care Company Shares by Value 2007-2011
  • Table 64 Eye Care Brand Shares by Value 2008-2011
  • Table 65 Forecast Sales of Eye Care by Category: Value 2011-2016
  • Table 66 Forecast Sales of Eye Care by Category: % Value Growth 2011-2016

Herbal/Traditional Products in Sweden - Category Analysis

HEADLINES

TRENDS

  • A wider consumer interest in natural ingredients was a key trend supporting the growth of herbal/traditional products in Sweden in 2011. This trend was most evident in packaged food and non-alcoholic drinks sales but increasingly transferred to consumer health.

COMPETITIVE LANDSCAPE

  • Procter & Gamble Sweden leads sales with a value share of 19% in 2011. The company’s strong position is due to its lead in herbal/traditional cold, cough and allergy remedies where it leads medicated confectionery sales. The company’s leading brand, Vicks, enjoys access to a wide and varied distribution network in Sweden.

PROSPECTS

  • A wider consumer interest in natural ingredients will remain key in supporting herbal/traditional products value growth over the forecast period in Sweden. However, the increasing maturity of sales, and the increased price competition this entails, will have a negative impact on forecast period growth. Consequently, the constant value CAGR for the forecast period is expected to be slower than the CAGR for the review period.

CATEGORY DATA

  • Table 67 Sales of Herbal/Traditional Products: Value 2006-2011
  • Table 68 Sales of Herbal/Traditional Products: % Value Growth 2006-2011
  • Table 69 Herbal/Traditional Products Company Shares 2007-2011
  • Table 70 Herbal/Traditional Products Brand Shares 2008-2011
  • Table 71 Forecast Sales of Herbal/Traditional Products: Value 2011-2016
  • Table 72 Forecast Sales of Herbal/Traditional Products: % Value Growth 2011-2016

Medicated Skin Care in Sweden - Category Analysis

HEADLINES

TRENDS

  • Competition from substitute products, in particular cosmetic skin care products, represented a key challenge to the value growth of medicated skin care in Sweden in 2011. This was due to the increasingly advanced and complex nature of cosmetic skin care offerings which made the differences between cosmetic skin care and medicated skin care products less obvious, resulting in consumers finding it difficult to differentiate between the two. This was especially the case with consumers unfamiliar with medicated skin care brands and product offerings. This had a negative impact on value growth in 2011 and resulted in a slower CAGR for this year compared to the review period.

SWITCHES

COMPETITIVE LANDSCAPE

  • Antula Healthcare AB is the market leader with a value share of 14% in 2011. The company controls a number of popular and strong medicated skin care brands in Sweden such as the cold sore treatment Anti and the haemorrhoid treatment AC3 Comfort. Both Anti and AC3 Comfort are leading brands in high growth segments of medicated skin care. This helped the growth of Antula’s total medicated skin care sales and supported its leading position.

PROSPECTS

  • Increased competition from substitute product categories such as cosmetic skin care represents a challenge to the future value growth of medicated skin care in Sweden. On the other hand, the growing self-medication trend represents an opportunity for forecast period value growth. Swedish consumers are more confident and comfortable in their ability to self-diagnose and self-medicate minor aliments. This represents an opportunity for medicated skin care to increase value sales.

CATEGORY DATA

  • Table 73 Sales of Medicated Skin Care by Category: Value 2006-2011
  • Table 74 Sales of Medicated Skin Care by Category: % Value Growth 2006-2011
  • Table 75 Medicated Skin Care Company Shares by Value 2007-2011
  • Table 76 Medicated Skin Care Brand Shares by Value 2008-2011
  • Table 77 Hair Loss Treatments Brand Shares by Value 2008-2011
  • Table 78 Forecast Sales of Medicated Skin Care by Category: Value 2011-2016
  • Table 79 Forecast Sales of Medicated Skin Care by Category: % Value Growth 2011-2016

NRT Smoking Cessation Aids in Sweden - Category Analysis

HEADLINES

TRENDS

  • Increased consumer health awareness encouraged consumers to stop smoking in 2011. The review period witnessed a strong decrease in the number of smokers in Sweden from 1,066,000 in 2006 to 921,000 in 2011, a decrease of 14%. Regulatory changes, such as the ban on smoking in public places, also encouraged consumers to stop smoking. These factors were key drivers of NRT smoking cessation aids sales in Sweden.

SWITCHES

COMPETITIVE LANDSCAPE

  • 2011 saw McNeil Sweden edge ahead of Novartis Sverige for the first time in terms of sales, though both companies recorded a category share of 42%. McNeil benefited from its two new launches in 2011; the Nicorette Pepparmint Spray and Nicorette Mint lozenges.

PROSPECTS

  • Increased consumer health awareness will have an impact on NRT smoking cessation performance over the forecast period as there will be an increase in the number of consumers stopping smoking looking for products to hep them. The number of smokers in Sweden is expected to decrease in the forecast period from 921,000 in 2011 to 908,000 in 2016.

CATEGORY INDICATORS

  • Table 80 Number of Smokers by Gender 2006-2011

CATEGORY DATA

  • Table 81 Sales of NRT Smoking Cessation Aids by Category: Value 2006-2011
  • Table 82 Sales of NRT Smoking Cessation Aids by Category: % Value Growth 2006-2011
  • Table 83 NRT Gum Flavours: % Value Breakdown 2006-2011
  • Table 84 NRT Smoking Cessation Aids Company Shares by Value 2007-2011
  • Table 85 NRT Smoking Cessation Aids Brand Shares by Value 2008-2011
  • Table 86 Forecast Sales of NRT Smoking Cessation Aids by Category: Value 2011-2016
  • Table 87 Forecast Sales of NRT Smoking Cessation Aids by Category: % Value Growth 2011-2016

OTC Triptans in Sweden - Category Analysis

HEADLINES

TRENDS

  • The growing self-medication trend was a key driver of sales in 2011. OTC triptans products are most likely to be purchased by consumers who believe they are suffering from a migraine but who have not been diagnosed by a medical professional.

SWITCHES

COMPETITIVE LANDSCAPE

  • AstraZeneca AB leads with a 2011 value share of 81%. The company is the NBO of the leading brand Zomig Nasal. Zomig Nasal was the first OTC triptans brand to gain OTC status in Sweden. AstraZeneca capitalised on its first-mover advantage by extensively promoting its brand to build a dominant market share. This was achieved through the building of strong distribution relationships and heavy advertising campaigns.

PROSPECTS

  • The self-medication trend will remain a key driver of forecast growth. Swedish consumers are less likely to seek professional medical advice due to the inconvenience and cost.

CATEGORY DATA

  • Table 88 Sales of OTC Triptans: Value 2008-2011
  • Table 89 Sales of OTC Triptans: % Value Growth 2008-2011
  • Table 90 OTC Triptans Company Shares by Value 2007-2011
  • Table 91 OTC Triptans Brand Shares by Value 2008-2011
  • Table 92 Forecast Sales of OTC Triptans: Value 2011-2016
  • Table 93 Forecast Sales of OTC Triptans: % Value Growth 2011-2016

Sports Nutrition in Sweden - Category Analysis

HEADLINES

TRENDS

  • Consumer realisation that good health depends on diet and exercise was a key trend shaping value growth. Greater availability and distribution of sports nutrition products was also a key trend in shaping value growth.

COMPETITIVE LANDSCAPE

  • Sports nutrition in Sweden remains fragmented with a high number of players. However, there was an evident trend towards increased consolidation during the review period.

PROSPECTS

  • The continued and growing health consciousness of consumers will remain a key driver of forecast period growth. Consumers believe that good health is dependent on diet and exercise.

CATEGORY DATA

  • Table 94 Sales of Sports Nutrition: Value 2006-2011
  • Table 95 Sales of Sports Nutrition: % Value Growth 2006-2011
  • Table 96 Sports Nutrition Company Shares 2007-2011
  • Table 97 Sports Nutrition Brand Shares 2008-2011
  • Table 98 Forecast Sales of Sports Nutrition: Value 2011-2016
  • Table 99 Forecast Sales of Sports Nutrition: % Value Growth 2011-2016

Vitamins and Dietary Supplements in Sweden - Category Analysis

HEADLINES

TRENDS

  • Consumer interest in vitamins and dietary supplements grew throughout the review period and in 2011. This was due to increased health awareness, greater product availability and distribution, an ageing population and rising health costs. In addition, the greater prevalence and awareness of lifestyle illnesses increased consumer interest in the ingredients of packaged foods and subsequent need to complement their diets with vitamins and dietary supplements.

VITAMINS

DIETARY SUPPLEMENTS

COMPETITIVE LANDSCAPE

  • The newly-formed entity Midsona Sverige AB leads sales with a value share of 20% in 2011. Midsona Sverige was formed following the merger of Friggs AB and MaxMedica AB in 2011.

PROSPECTS

  • Increased health consciousness will remain a key driver of forecast value growth. Consumer interest in their health and well-being will ensure a continued strong demand for products.

CATEGORY DATA

  • Table 100 Dietary Supplements: Brand Ranking by Positioning 2011
  • Table 101 Sales of Vitamins and Dietary Supplements by Category: Value 2006-2011
  • Table 102 Sales of Vitamins and Dietary Supplements by Category: % Value Growth 2006-2011
  • Table 103 Dietary Supplements by Positioning 2006-2011
  • Table 104 Vitamins and Dietary Supplements Company Shares by Value 2007-2011
  • Table 105 Vitamins and Dietary Supplements Brand Shares by Value 2008-2011
  • Table 106 Vitamins Brand Shares by Value 2008-2011
  • Table 107 Dietary Supplements Brand Shares by Value 2008-2011
  • Table 108 Forecast Sales of Vitamins and Dietary Supplements by Category: Value 2011-2016
  • Table 109 Forecast Sales of Vitamins and Dietary Supplements by Category: % Value Growth 2011-2016

Weight Management in Sweden - Category Analysis

HEADLINES

TRENDS

  • The historically high level of overweight and obese consumers, combined with the suggestion of increased health consciousness among the Swedish population, had a positive impact on the value growth of weight management. Weight management had annual value growth throughout the review period and in 2011. Weight management had value growth of 4% in 2011 with market players reported particularly strong growth for slimming teas.

COMPETITIVE LANDSCAPE

  • Axellus AB leads sales with a 2011 value share of 27%. The company is the NBO of the leading Nutrilett brand which has a long-established position.

PROSPECTS

  • Increased consumer health awareness and a greater willingness to address overweight and obesity issues will drive the value growth of weight management in the forecast period. Weight management products will be more widely distributed which will help to encourage its continued growth as it reaches new consumer groups.

CATEGORY DATA

  • Table 110 Sales of Weight Management: Value 2006-2011
  • Table 111 Sales of Weight Management: % Value Growth 2006-2011
  • Table 112 Weight Management Company Shares 2007-2011
  • Table 113 Weight Management Brand Shares 2008-2011
  • Table 114 Forecast Sales of Weight Management: Value 2011-2016
  • Table 115 Forecast Sales of Weight Management: % Value Growth 2011-2016

Wound Care in Sweden - Category Analysis

HEADLINES

TRENDS

  • Increased product segmentation driven by new innovations was a key driver of value growth for wound care in Sweden in 2011. New innovations such as Salvequick Foot Care and Salvequick Aqua Block by Cederroth AB in 2010 were essential to retain consumer interest and to encourage consumers to pay a premium for new innovations in order to drive value growth.

COMPETITIVE LANDSCAPE

  • Cederroth AB leads sales with a 2011 value share of 41% in 2011. Cederroth is the NBO of the popular and widely recognised Salvequick brand, which enjoys mass market distribution across grocery retailers, non-grocery retailers and non-store retailing channels. Salvequick is branded as Salvemed in the chemists/pharmacies channel.

PROSPECTS

  • New product innovations and subsequent development of product segmentation and growth niches will remain important for the future value growth of wound care in Sweden.

CATEGORY DATA

  • Table 116 Sales of Wound Care by Category: Value 2006-2011
  • Table 117 Sales of Wound Care by Category: % Value Growth 2006-2011
  • Table 118 Wound Care Company Shares by Value 2007-2011
  • Table 119 Wound Care Brand Shares by Value 2008-2011
  • Table 120 Forecast Sales of Wound Care by Category: Value 2011-2016
  • Table 121 Forecast Sales of Wound Care by Category: % Value Growth 2011-2016

Segmentation

Segmentation

This market research report includes the following:

  • Consumer Health
    • OTC
      • Adult Mouth Care
      • Analgesics
        • Systemic Analgesics
          • Adult Analgesics
            • Acetaminophen
            • Aspirin
            • Combination Products - Analgesics
            • Diclofenac
            • Dipyrone
            • Ibuprofen
            • Ketoprofen
            • Naproxen
          • Paediatric Analgesics
            • Paediatric Acetaminophen
            • Paediatric Aspirin
            • Paediatric Combination Products - Analgesics
            • Paediatric Diclofenac
            • Paediatric Dipyrone
            • Paediatric Ibuprofen
            • Paediatric Ketoprofen
            • Paediatric Naproxen
        • Topical Analgesics/Anaesthetic
      • Calming and Sleeping
      • Cough, Cold and Allergy (Hay Fever) Remedies
        • Antihistamines/Allergy Remedies (Systemic)
        • Paediatric Cough, Cold and Allergy Remedies
          • Paediatric Allergy Remedies
          • Paediatric Cough/Cold Remedies
        • Combination Products - Cough, Cold and Allergy (Hay Fever) Remedies
        • Cough Remedies
        • Decongestants
          • Nasal Sprays
          • Oral Decongestants
          • Inhalant Decongestants
          • Decongestant Rubs
          • Nasal Decongestant Drops
          • Nasal Decongestant Plasters
        • Medicated Confectionery
        • Pharyngeal Preparations
      • Digestive Remedies
        • Paediatric Digestive Remedies
          • Paediatric Diarrhoeal Remedies
          • Paediatric Indigestion and Heartburn Remedies
          • Paediatric Laxatives
          • Paediatric Motion Sickness Remedies
        • Diarrhoeal Remedies
        • IBS Treatments
        • Indigestion and Heartburn Remedies
          • Antacids
          • Antiflatulents
          • Digestive Enzymes
          • H2 Blockers
          • Proton Pump Inhibitors
        • Laxatives
        • Motion Sickness Remedies
      • Ear Care
      • Emergency Contraception
      • Eye Care
        • Allergy Eye Care
        • Standard Eye Care
      • Medicated Skin Care
        • Medicated Shampoos
        • Topical Antifungals
        • Vaginal Antifungals
        • Hair Loss Treatments
        • Nappy (Diaper) Rash Treatments
        • Antiparasitics/Lice (Head and Body) Treatments
        • Antipruritics
        • Paediatric Medicated Skin Care
        • Cold Sore Treatments
        • Haemorrhoid Treatments
        • Topical Allergy Remedies/Antihistamines
        • Topical Germicidals/Antiseptics
      • NRT Smoking Cessation Aids
        • NRT Gum
        • NRT Inhalators
        • NRT Lozenges
        • NRT Patches
        • Other NRT
      • OTC Triptans
      • Wound Care
        • First Aid Kits
        • Sticking Plasters/Adhesive Bandages
        • Gauze, Tape and Other Wound Care
    • Sports Nutrition
      • Protein Products
        • Bars
        • Powder
        • RTD
        • Other Protein
      • Non-Protein Products
    • Vitamins and Dietary Supplements
      • Paediatric Vitamins and Dietary Supplements
      • Dietary Supplements
        • Combination Dietary Supplements
        • Herbal/Traditional Dietary Supplements
          • Combination Herbal/Traditional Dietary Supplements
          • Echinacea
          • Evening Primrose Oil
          • Garlic
          • Ginkgo Biloba
          • Ginseng
          • St John's Wort
          • Other Herbal/Traditional Dietary Supplements
            • Guarana
            • Rosehip
            • Roseroot
            • Other Other Herbal/Traditional Dietary Supplements
        • Non-Herbal Dietary Supplements
          • Calcium Supplements
          • Co-Enzyme Q10
          • Combination Non-Herbal Dietary Supplements
          • Eye Health Supplements
          • Fish Oils
            • Cod Liver Oil
            • Other Fish Oils
          • Glucosamine
          • Mineral Supplements
          • Omega-3-6-9 (Fish and Non-Fish)
          • Probiotic Supplements
          • Protein Powder
          • Royal Jelly
          • Sam-E
          • Other Non-Herbal Dietary Supplements
            • Yeast
      • Tonics and Bottled Nutritive Drinks
      • Vitamins
        • Multivitamins
        • Single Vitamins
          • Vitamin A
          • Vitamin B
          • Vitamin C
          • Vitamin D
          • Vitamin E
          • Other Single Vitamins
    • Weight Management
      • Meal Replacement Slimming
      • OTC Obesity
      • Slimming Teas
      • Weight Loss Supplements
      • Other Slimming Products
    • Herbal/Traditional Products
      • Herbal/Traditional Analgesics
      • Herbal/Traditional Calming and Sleeping Products
      • Herbal/Traditional Cough, Cold and Allergy (Hay Fever) Remedies
      • Herbal/Traditional Digestive Remedies
      • Herbal/Traditional Medicated Skin Care
      • Herbal/Traditional Medicinal Teas
      • Herbal/Traditional Smoking Cessation Aids
      • Herbal/Traditional Paediatric Dietary Supplements
      • Herbal/Traditional Dietary Supplements
      • Herbal/Traditional Tonics and Bottled Nutritive Drinks
    • Allergy Care
      • Allergy Eye Care
      • Antihistamines/Allergy Remedies (Systemic)
      • Paediatric Allergy Remedies
      • Topical Allergy Remedies/Antihistamines
    • Paediatric Consumer Health
      • Paediatric Analgesics
        • Paediatric Acetaminophen
        • Paediatric Aspirin
        • Paediatric Combination Products - Analgesics
        • Paediatric Diclofenac
        • Paediatric Dipyrone
        • Paediatric Ibuprofen
        • Paediatric Ketoprofen
        • Paediatric Naproxen
      • Paediatric Cough, Cold and Allergy Remedies
        • Paediatric Allergy Remedies
        • Paediatric Cough/Cold Remedies
      • Paediatric Digestive Remedies
        • Paediatric Diarrhoeal Remedies
        • Paediatric Indigestion and Heartburn Remedies
        • Paediatric Laxatives
        • Paediatric Motion Sickness Remedies
      • Paediatric Medicated Skin Care
      • Nappy (Diaper) Rash Treatments
      • Paediatric Vitamins and Dietary Supplements

Statistics Included

Statistics Included

For each category and subcategory you will receive the following data in Excel format:

From Passport

  • Market sizes
  • Company shares
  • Brand shares
  • Distribution
  • Analysis by format
  • Analysis by positioning
  • Analysis by type
  • Herbal/traditional vs standard
  • Pricing
  • Smoking population - number of adult smokers
  • Smoking prevalence - % of adult population

Market size details:

  • Retail volume
  • Retail volume % growth
  • Retail volume per capita
  • Retail value retail selling price % growth
  • Retail value retail selling price local currency, USD, EUR, GBP, CHF, JPY
  • Retail value retail selling price per capita local currency, USD, EUR, GBP, CHF, JPY
  • Retail value manufacturer selling price % growth
  • Retail value manufacturer selling price local currency, USD, EUR, GBP, CHF, JPY
  • Retail value manufacturer selling price per capita local currency, USD, EUR, GBP, CHF, JPY

Methodology

Methodology

Global insight and local knowledge

With 40 years’ experience of developed and emerging markets, Euromonitor International’s research method is built on a unique combination of specialist industry knowledge and in-country research expertise.

This approach is what enables us to achieve our goal of building a market consensus view of size, shape and trends across the full distribution universe of each category. We factor in whichever channels are relevant, from large-scale grocery to direct sellers, from discount stores to local mom-and-pop outlets.

Industry specialists

Each industry we cover is managed by an Industry Manager and team of Industry Analysts who research and report on their specialist categories all year round.

Our collaborative approach to research means that these industry teams are in constant dialogue with industry players and opinion formers. The planning of our research programmes reflects latest market trends and industry events. In completing each update project, this provides invaluable input to the testing, review and finalisation of our data.

The specialist in-house teams bring together findings from all stages of the annual research process. They work closely with in-country analysts, assess and challenge data and exercise final editorial control over the publication of new data and analysis.

Country and regional analysts

Our in-country analyst network is managed by country and regional analysts in our offices around the world. Working closely with each in-country team, the regional research management team ensures that all country researchers are well schooled in best practices, from the information collected in store checks, to the dialogue we build in trade surveys. Our country analysts ensure that national reports explain the data trends and provide clear insights into the local market’s dynamics.

In-country research network

To deliver fresh insights every year in countries all around the world, we believe the strongest approach is to use analysts on the ground. They bring fluency in local language, physical proximity to the best sources, an ability to engage directly with local industry contacts, and an awareness of how the products and services we study are advertised, sold and consumed. These are essential parts of our ability to report incisively on these markets.

Research Methodology

Our research methods

Each Euromonitor International industry report is based on a core set of research techniques:

Desk research

With industry events, corporate activity, trends and new product introductions tracked year round by our industry team, desk research provides a starting point for the in-country research programme. Our in-country researchers will access the following sources:

  • National statistics offices governmental and official sources
  • National and international trade press
  • National and international trade associations
  • Industry study groups and other semi-official sources
  • Company financials and annual reports
  • Broker reports
  • Online databases
  • The financial, business and mainstream press

Accessing sources is only the first step. The ability to interpret and reconcile often conflicting information across multiple sources is a key aspect of the added value we provide.

Store checks

Store checks are an integral part of our methods for product industries. Carried out on the ground across a relevant mix of channels, the information gained provides first-hand insights into the products we are researching, specifically:

  • Place: We track products in all relevant channels, selective and mass, store and non-store
  • Product: What are innovations in products, pack sizes and formats?
  • Price: What are brand price variations across channels, how do private label’s prices compare to those of branded goods?
  • Promotion: What are marketing and merchandising trends, offers, discounts and tie-ins?

Findings are cross-referenced with brand share data analysis. The results, combined with the findings of desk research, provide a strong basis for identifying key areas of questioning to take forward into our trade survey.

Trade survey

Interaction with global players at corporate HQ and regional levels is complemented by unique local data and insights from our in-country trade surveys around the world. Through the high profile of the Euromonitor International brand, we are able to talk directly to a wide range of sources and therefore inform our analysis with the knowledge and opinions of the leading operators in the market.

Trade surveys allow us to:

  • Fill gaps in available published data per company
  • Generate a consensus view of the size, structure and strategic direction of the category
  • Access year-in-progress data where published sources are out of date
  • Evaluate the experts’ views on current trends and market developments

In building our composite industry view, we engage with a variety of personnel in key players at all points of the supply chain: materials suppliers, manufacturers, distributors, retailers and service operators. We also interview desk research sources: industry associations; study groups; and third party observers from the trade and financial press.

Our objective is to engage in conversation with trade sources in which we exchange ideas and views on the industry, sharing our work-in-progress findings on supply/demand dynamics and potential. This dialogue enhances both parties’ understanding of the local market. The scope and reach of our trade survey also serves to eliminate bias (intentional and unintentional) from any single source.

Company analysis

At a global level, our company research combines our mix of industry interaction and use of secondary sources such as annual accounts, broker reports, financial press and databases. From a data perspective, the aim is to build “top-down” estimates of major players’ total global and regional sales.

At a country level, in line with local reporting requirements, we access annual accounts, national-specific company databases and local company websites. These are all invaluable sources as we build a view of each domestic player’s size and position within very specific categories of the industry.

Forecasts

Data projections and future performance analysis are key elements of Euromonitor International’s market intelligence. Working with historic trends of 15 years or more, a key aspect of our trade survey is to engage industry insider views of the next five years. Will volumes maintain their historic trend? Will price increases or falls of recent years continue, accelerate or slow down? Will increasing demand for one product cannibalise sales of another?

Forecasts represent many of the essential conclusions we have reached about the current state of the market, how it works and how it behaves under different macro and micro conditions. Our written analysis will state the assumptions and the trade opinion behind whether our predictions are optimistic or pessimistic, so that clients can use our statistical forecasts with confidence.

Data validation

All data is subjected to an exhaustive review process, at country, regional and global levels.

The interpretation and review of sources and data inputs forms a central part of the collaboration between industry teams and country researchers. Numbers are delivered to regional and global offices with an audit trail of sources and calculations to allow for a thorough evaluation of data sense and integrity.

Upon completion of the country review phase, data is then reviewed on a comparative basis at regional and then at a global level. Comparative checks are carried out on per capita consumption and spending levels, growth rates, patterns of category and subcategory breakdowns and distribution of sales by channel. Top-down estimates are reviewed against bottom-up regional and global market and company sales totals.

Where marked differences are seen between proximate country markets or ones at similar developmental levels, supplementary research is conducted in the relevant countries to confirm and/or amend those findings. This process ensures international comparability across the database, that consistent category and subcategory definitions have been used and that all data has been correctly tested. We make sure that possible discrepancies between different published sources have been reconciled and that our interpretation of opinion and expectation from each country’s trade sources has been applied to form a coherent international pattern.

Market analysis

Another integral part of all our research programmes is that all Euromonitor International data is accompanied by clear written analysis. From a research perspective, this explains and substantiates data findings. From a client perspective, this offers unique insights into local consumption trends, routes to market, brand preferences, channel dynamics and future trends.

Our country level analysis also provides invaluable input into the ability of our central industry specialist teams to marry local insights with strategic conclusions on the direction of the market regionally and globally.

my pages

Want to find out more about this report?

If you purchase a report that is updated in the next 60 days, we will send you the new edition of the report and the data extract FREE!